Characterization of enhanced 45Ca2+ efflux in cultured vascular smooth muscle cells from spontaneously hypertensive rats

Am J Hypertens. 1995 Oct;8(10 Pt 1):1015-22. doi: 10.1016/0895-7061(95)00226-X.

Abstract

In this study we have compared Ca2+ efflux in cultured aortic smooth muscle cells derived from male, 10-week-old spontaneously hypertensive and Wistar-Kyoto rats. The role of Ca(2+)-dependent protein kinase C and Ca2+ uptake in the regulation of the Ca2+ pump and Na(+)-Ca2+ exchange mediated Ca2+ efflux were investigated. Basal, angiotensin II, and ionomycin-stimulated Ca2+ effluxes were significantly higher in spontaneously hypertensive rats. Brief (5 min) or prolonged (3 h) incubation of the cells with 100 nmol/L 12-O-tetradecanoylphorbol-13-O-acetate (TPA), a protein kinase C stimulator, did not significantly affect the maximum Ca2+ efflux rate in either strain. However, the Ca2+ efflux rates at early timepoints in Wistar-Kyoto rats were increased by TPA, but not in spontaneously hypertensive rats. Incubation of cells with [45Ca]-labeled CaCl2 in balanced salt solution for 4 h led to greater Ca uptake in spontaneously hypertensive rats compared to Wistar-Kyoto controls. Verapamil (1 mumol/L) for 4 h reduced the cellular Ca content of spontaneously hypertensive rats by 30% to the level of Wistar-Kyoto rats; it also reduced the Ca content in Wistar-Kyoto rats, but to a lesser extent (18%). In parallel, Ca2+ efflux was also reduced by verapamil to a greater extent in spontaneously hypertensive rats than in Wistar-Kyoto rats. We conclude that Ca2+ efflux was enhanced in spontaneously hypertensive rats by a mechanism partly associated with greater Ca2+ uptake by a verapamil-sensitive pathway and possibly an alteration of protein kinase C regulation. However, an up-regulation of the number or efficiency of Ca2+ efflux sites may also significantly contribute as an adaptive response to enhanced Ca2+ influx.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / agonists
  • Calcium / metabolism*
  • Calcium / pharmacokinetics
  • Calcium Channel Blockers / pharmacology
  • Calcium Radioisotopes
  • Cells, Cultured
  • Hypertension / genetics
  • Hypertension / metabolism*
  • Hypertension / pathology
  • Ionomycin / pharmacology
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Muscle, Smooth, Vascular / pathology
  • Rats
  • Rats, Inbred SHR
  • Tetradecanoylphorbol Acetate / pharmacology
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Calcium Radioisotopes
  • Ionomycin
  • Verapamil
  • Tetradecanoylphorbol Acetate
  • Calcium